Altered prion protein glycosylation in the aging mouse brain

The normal cellular prion protein (PrPC) is a glycoprotein with two highly conserved potential N‐linked glycosylation sites. All prion diseases, whether inherited, infectious or sporadic, are believed to share the same pathogenic mechanism that is based on the conversion of the normal cellular prion protein (PrPC) to the pathogenic scrapie prion protein (PrPSc). However, the clinical and histopathological presentations of prion diseases are heterogeneous, depending not only on the strains of PrPSc but also on the mechanism of diseases, such as age‐related sporadic vs. infectious prion diseases. Accumulated evidence suggests that N‐linked glycans on PrPC are important in disease phenotype. A better understanding of the nature of the N‐linked glycans on PrPC during the normal aging process may provide new insights into the roles that N‐linked glycans play in the pathogenesis of prion diseases. By using a panel of 19 lectins in an antibody–lectin enzyme‐linked immunosorbent assay (ELISA), we found that the lectin binding profiles of PrPC alter significantly during aging. There is an increasing prevalence of complex oligosaccharides on the aging PrPC, which are features of PrPSc. Taken together, this study suggests a link between the glycosylation patterns on PrPC during aging and PrPSc.

[1]  Tong Liu,et al.  Heterogeneity of normal prion protein in two‐dimensional immunoblot: presence of various glycosylated and truncated forms , 2002, Journal of neurochemistry.

[2]  D. Harris,et al.  Blockade of Glycosylation Promotes Acquistion of Scrapie-like Properties by the Prion Protein in Cultured Cells* , 1997, The Journal of Biological Chemistry.

[3]  K. Winklhofer,et al.  Inhibition of Complex Glycosylation Increases the Formation of PrPsc , 2003, Traffic.

[4]  U. Rutishauser,et al.  Roles, regulation, and mechanism of polysialic acid function during neural development. , 2001, Biochimie.

[5]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[6]  S. Prusiner,et al.  Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. , 1989, Biochemistry.

[7]  L. Hood,et al.  Asparagine-linked glycosylation of the scrapie and cellular prion proteins. , 1989, Archives of biochemistry and biophysics.

[8]  R. B. Petersen,et al.  Typing prion isoforms , 1997, Nature.

[9]  M. Sy,et al.  Novel Antibody-Lectin Enzyme-Linked Immunosorbent Assay That Distinguishes Prion Proteins in Sporadic and Variant Cases of Creutzfeldt-Jakob Disease , 2005, Journal of Clinical Microbiology.

[10]  L. Forestier,et al.  Glycosylation-related Gene Expression in Prion Diseases , 2005, Journal of Biological Chemistry.

[11]  A. Burlingame,et al.  Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. , 1999, Biochemistry.

[12]  D. Teplow,et al.  Truncated Forms of the Human Prion Protein in Normal Brain and in Prion Diseases (*) , 1995, The Journal of Biological Chemistry.

[13]  D. Burton,et al.  Copper refolding of prion protein. , 2000, Biochemical and biophysical research communications.

[14]  Alberto Rábano,et al.  Altered glycosylation of acetylcholinesterase in Creutzfeldt–Jakob disease , 2006, Journal of neurochemistry.

[15]  S. Prusiner,et al.  Prion glycoprotein: structure, dynamics, and roles for the sugars. , 2001, Biochemistry.

[16]  N. Salès,et al.  Developmental expression of the cellular prion protein in elongating axons , 2002, The European journal of neuroscience.

[17]  T. Wisniewski,et al.  Biochemical Fingerprints of Prion Infection: Accumulations of Aberrant Full-Length and N-Terminally Truncated PrP Species Are Common Features in Mouse Prion Disease , 2005, Journal of Virology.

[18]  D. Zopf,et al.  Molecular mass, biochemical composition, and physicochemical behavior of the infectious form of the scrapie precursor protein monomer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Prusiner,et al.  Glycosylation differences between the normal and pathogenic prion protein isoforms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Prusiner,et al.  Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Mark A. Smith,et al.  Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein , 2001, Journal of neurochemistry.

[22]  B. Ghetti,et al.  Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. , 1998, The American journal of pathology.

[23]  L. Hood,et al.  Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. , 1993, Biochemistry.

[24]  A. Hill,et al.  Prion protein glycosylation , 2005, Journal of neurochemistry.

[25]  W. Surewicz,et al.  Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. , 2000, Journal of molecular biology.

[26]  N. Greenspan,et al.  Mapping the antigenicity of copper-treated cellular prion protein with the scrapie isoform , 2003, Cellular and Molecular Life Sciences CMLS.

[27]  Stanley B. Prusiner,et al.  Scrapie prion protein contains a phosphatidylinositol glycolipid , 1987, Cell.

[28]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[29]  R. Somerville,et al.  Differential glycosylation of the protein (PrP) forming scrapie-associated fibrils. , 1990, The Journal of general virology.

[30]  S. Priola,et al.  Glycosylation influences cross‐species formation of protease‐resistant prion protein , 2001, The EMBO journal.

[31]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[32]  R. Somerville,et al.  Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc. , 2005, The Journal of general virology.

[33]  T. Bergman,et al.  Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells. , 2004, The Biochemical journal.

[34]  M. Sy,et al.  Biochemical fingerprints of prion diseases: scrapie prion protein in human prion diseases that share prion genotype and type , 2005, Journal of neurochemistry.

[35]  S. Prusiner,et al.  Scrapie PrP 27-30 is a sialoglycoprotein , 1985, Journal of virology.

[36]  S. Hornemann,et al.  Prion protein expression in different species: analysis with a panel of new mAbs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  K. Reifenberg,et al.  Glycosylation Deficiency at Either One of the Two Glycan Attachment Sites of Cellular Prion Protein Preserves Susceptibility to Bovine Spongiform Encephalopathy and Scrapie Infections* , 2004, Journal of Biological Chemistry.